Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Venous Thromboembolism × Dalteparin × Clear all

Phase

Status

Completed 10 Terminated 4 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Pulmonary Embolism 1 Gastrointestinal Neoplasms 1

Interventions

ribociclib 1 palbociclib 1 edoxaban 1 apixaban 1 abemaciclib 1 abelacimab 1 Rivaroxaban 1 MAA868 1 Heparin, Low-Molecular-Weight 1 Dalteparin 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05171075 2025-12-19

MAGNOLIA

Anthos Therapeutics, Inc.

Phase 3 Active not recruiting

Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡